Dr. Friedrich von Bohlen
Dr. Friedrich von Bohlen und Halbach is CEO and co-founder of Molecular Health GmbH.
Dr. Stephan Brock
Dr. Stephan Brock is Chief Technology Officer and co-founder of Molecular Health GmbH.
Tumor mutational burden
The Tumor Mutational Burden (TMB) is a genomic biomarker. At first glance, the biomarker seems to be easy to detect as a simple...Download
Sample quality and its influence
How tumor sample quality and NGS data quality influence the detected tumor variant frequency.
Agena technology and MH Guide software: A perfect fit for quick and convenient tumor analysis.
BRCA reverse frameshifts
Pathogenic variants in BRCA1 and BRCA2 occur in 45% of all breast cancer cases and can be a strong signal for effective treatment with PARP-Inhibitors.Download
Are you a media representative and need information about Molecular Health? – Feel free to get in touch with our media contact below.
Head of Global Marketing & PR
Molecular Health GmbH
Phone: +49 (0) 6221 – 43851 2280
Fax: +49 (0) 6221 – 43851 2780
Join our Team!
Our solutions are only as smart as the people behind them. This is why we are always looking for motivated employees from a variety of different fields and many different backgrounds. – Come work for and with us on the digital health of today and tomorrow!